Does NELVUTAMIG Cause Off label use? 29 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Off label use have been filed in association with NELVUTAMIG. This represents 10.5% of all adverse event reports for NELVUTAMIG.
29
Reports of Off label use with NELVUTAMIG
10.5%
of all NELVUTAMIG reports
6
Deaths
12
Hospitalizations
How Dangerous Is Off label use From NELVUTAMIG?
Of the 29 reports, 6 (20.7%) resulted in death, 12 (41.4%) required hospitalization, and 6 (20.7%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NELVUTAMIG. However, 29 reports have been filed with the FAERS database.
What Other Side Effects Does NELVUTAMIG Cause?
Immune-mediated hepatitis (18)
Hypothyroidism (17)
Immune-mediated enterocolitis (16)
Malignant neoplasm progression (16)
Colitis (15)
Drug ineffective (14)
Immune-mediated hepatic disorder (14)
Fatigue (13)
Immune-mediated myocarditis (11)
Diarrhoea (10)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which NELVUTAMIG Alternatives Have Lower Off label use Risk?
NELVUTAMIG vs NEMOLIZUMAB
NELVUTAMIG vs NEMOLIZUMAB-ILTO
NELVUTAMIG vs NEOMYCIN
NELVUTAMIG vs NEORAL
NELVUTAMIG vs NEOSTIGMINE